Telangana, India

Somnath Devidas Navgire

USPTO Granted Patents = 2 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2024

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Somnath Devidas Navgire in Pharmaceutical Compositions

Introduction

Somnath Devidas Navgire is an accomplished inventor based in Telangana, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compositions that enhance the bioavailability of mifepristone. With a total of two patents to his name, Navgire's work is pivotal in advancing treatment options for various disorders.

Latest Patents

Navgire's latest patents focus on pharmaceutical compositions of mifepristone. These compositions include stable nano-suspensions that comprise mifepristone and at least one pharmaceutically acceptable excipient. They exhibit enhanced bioavailability compared to currently marketed formulations. The patents also detail the manufacturing processes and methods of use for these compositions, which are intended for the prevention, treatment, or prophylaxis of disorders in human patients. Additionally, oral pharmaceutical compositions of mifepristone are described, along with methods for their administration and processes for their production.

Career Highlights

Somnath Devidas Navgire is currently associated with Slayback Pharma LLC, where he continues to innovate in the pharmaceutical sector. His work is characterized by a commitment to improving patient outcomes through advanced drug formulations.

Collaborations

Navgire collaborates with notable professionals in the field, including Paras P Jain and Sumitra Ashokkumar Pillai. These collaborations enhance the research and development efforts at Slayback Pharma LLC.

Conclusion

Somnath Devidas Navgire's contributions to pharmaceutical innovations, particularly in mifepristone formulations, underscore his role as a key inventor in the industry. His patents reflect a dedication to improving therapeutic options for patients in need.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…